View Single Post
Old 10-07-2009, 02:20 PM   #47
Location: Pittsburgh, PA

Join Date: Oct 2009
Posts: 12
Default hello all

bioinformatics core director here with some questions, looking for advice

we have recently acquired the GS-FLX and the SoLiD. We are constructing a pricing model. Simple question: would you expect the cost of analysis (say, alignment and annotation) to scale linearly within a project; i.e., will a project that requires two chips cost twice as much to perform data analysis for as a project that requires one chip). Assuming one sample per chip.

We have created regulatory compliant cost structures for genomics and proteomics. But only starting with the first project on SoLId, and, of course we are getting request for cost estimates for data analysis for grant proposals and for funded projects.

Any feedback would be appreciated.
bacdirector is offline